Chinese Pulmonary Vascular Disease Research Group is the lead sponsor of 5 current clinical trials in our China register. 5 are recruiting patients now. All registered phases are Observational. The most-studied condition is Pulmonary Hypertension.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension
NCT05566002 · ClinicalTrials.gov ↗ · Pulmonary Hypertension, Pulmonary Arterial Hypertension
|
Observational | Recruiting | 2022-06 | China |
|
Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
NCT05388682 · ClinicalTrials.gov ↗ · Takayasu Arteritis With Pulmonary Artery Involvement, Percutaneous Transluminal Pulmonary Angioplasty, PAH Targeted Medication
|
Observational | Recruiting | 2014-01 | China |
|
Safety and Efficacy of Balloon Pulmonary Angioplasty in China
NCT04206852 · ClinicalTrials.gov ↗ · Chronic Thromboembolic Pulmonary Hypertension
|
Observational | Recruiting | 2018-05 | China |
|
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
NCT02061787 · ClinicalTrials.gov ↗ · Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
|
Observational | Recruiting | 2010-09 | China |
|
CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy
NCT06135909 · ClinicalTrials.gov ↗ · Pulmonary Hypertension
|
Observational | Recruiting | 2020-01 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 5 | 5 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Pulmovant | 3 |
| Insmed Incorporated | 2 |
| 35Pharma | 1 |
| Tenax Therapeutics | 1 |
| Tempus AI | 1 |
| Eko Devices | 1 |
Sponsors with the most current trials registered for this condition.
Chinese Pulmonary Vascular Disease Research Group is the lead sponsor of 5 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 5 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.